Overview
The aim of our study is to investigate the effects of pelvic floor muscle strengthening exercises with EMG-Biofeedback and pelvic floor muscle strengthening exercises with Rebound therapy on pelvic floor muscle strength, pain level, NGF level, perceived stress level, quality of life and sleep in women diagnosed with endometriosis.
Description
Endometriosis is a chronic, systematic, inflammatory, estrogen-dependent public health problem characterized by the growth of endometrial-like tissue outside the uterine cavity, including the pelvic peritoneum, rectovaginal septum and ovaries, and is particularly seen in women of reproductive age and significantly affects quality of life. The aim of our study is to investigate the effects of pelvic floor muscle strengthening exercises with EMG-Biofeedback and pelvic floor muscle strengthening exercises with Rebound therapy on pelvic floor muscle strength, pain level, NGF level, perceived stress level, quality of life and sleep in women diagnosed with endometriosis. The study will consist of 3 groups. Group 1: EMG-Biofeedback group, Group 2: Rebound Therapy Group and Group 3: Home Exercises Group. Participants will be included in the study for 8 weeks. During the evaluation, pelvic floor muscle strength will be assessed with EMG, pain level with Visual Analog Scale (VAS), perceived stress level with Perceived Stress Scale, quality of life with Endometriosis Health Profile Questionnaire (EHP-30), and sleep quality with Pittsburgh Sleep Quality Index (PSQI). NGF analysis will be evaluated by analyzing serum samples of patients with ELISA kit. Evaluations will be made before and after treatment.
Eligibility
Inclusion Criteria:
- Being between 20-50 years old,
- Being diagnosed with endometriosis,
- Completing the voluntary consent form,
- Pain level being at least 4 on the Visual Analog Scale (VAS).
Exclusion Criteria:
Exclusion Criteria for the EMG-Biofeedback Group:
- Being included in another study during the study period,
- Being receiving medical treatment for endometriosis,
- Presence of gynecological bleeding,
- Presence of communication and cooperation problems,
- Presence of tubo-ovarian abscess,
- Active vaginal or urinary tract infection,
- Pregnancy and giving birth within the last 12 months,
- Presence of impaired somatosensory status,
- Not attending 2 consecutive sessions.
Exclusion Criteria for the Rebound Therapy Group:
In addition to the exclusion criteria determined for the EMG-Biofeedback Group;
- Presence of a neurological or orthopedic disease affecting the lower extremity,
- History of spine and/or lower extremity orthopedic surgery,
- Presence of severe arthritis affecting the spine and/or lower extremity,
- Presence of uncontrolled hypertension and cardiovascular disease.